Wei et al. (2014) revealed that expression level of serum GP73 was significantly up-regulated in patient with HBV-ACLF compared to HCC patients, CHB patients, and healthy controls, supporting our present result. Here, GOLM1 is linked to hepatocellular carcinoma.